Adeline Waltz|
Kristen McCauley joined the MJ team in 2014 as an account coordinator in our Risk Management + Commercial Insurance department. Kristen quickly transitioned to serving as a client advocate in our Manufacturing practice group, and has since moved into our Analytics practice as a data analyst.
In her role, Kristen produces, supports, and maintains a collection of analytics reports for key clients in partnership with the client service team. Kristen develops functional reports for clients and her team, and builds data maps to translate raw data into information. Kristen also writes data queries, interprets results, and works to display her findings in an easily digestible format using MJ’s proprietary analytics tool, APERTURE®.
Related Blogs
Employer Response to Pharma Shifts
Chris AntypasVolatility in the pharmaceutical industry, including the expanding specialty drug pipeline, increased utilization of GLP-1 medications, and persistent supply chain disruptions, are contributing to rising costs ...
Read More
White House Launches TrumpRx, Unveils Drug Prices
DeAnn DeckOn Feb. 5, President Donald Trump announced the launch of TrumpRx.gov, a federally operated website to help individuals buy prescription medications at discounted cash ...
Read More
DOL Issues Updated Model Employer CHIP Notice
DeAnn DeckThe U.S. Department of Labor (DOL), through its Employee Benefits Security Administration (EBSA), has released a new model Employer CHIP Notice with information current ...
Read More
Prescription Drug Reporting (RxDC Report)
DeAnn DeckThe No Surprises Act (NSA), enacted as part of the Consolidated Appropriations Act, 2021 (CAA), includes transparency provisions requiring group health plans to report ...
Read More
The MJ Foundation Awards $55,000 to Nashville Nonprofits Team Chad, Pathways Kitchen, and UpRise Nashville
Britni ShroutNASHVILLE (Jan. 26, 2026) – The MJ Charitable Foundation (the MJ Foundation) has made major gifts to three Nashville nonprofits as part of its ...
Read More
Major Federal PBM Reforms Enacted as DOL Proposes New PBM Fee-Disclosure Rule
DeAnn DeckFederal oversight efforts directed at the pharmaceutical benefit manager (PBM) industry have expanded in recent years, culminating in several significant actions. On Feb. 3, ...
Read More